IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights Read more about Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call Read more about Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference Read more about Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference Ardelyx Announces Pricing of Public Offering of Common Stock Read more about Ardelyx Announces Pricing of Public Offering of Common Stock Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank Read more about Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank Ardelyx Announces Proposed Public Offering of Common Stock Read more about Ardelyx Announces Proposed Public Offering of Common Stock Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights Read more about Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights Jan Lundberg Member of the Nominating and Governance Committee Jan Lundberg, Ph.D. Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada Read more about Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors Read more about Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors Pagination First page « First Previous page ‹ Previous … Page 15 Page 16 Page 17 Page 18 Current page 19 Page 20 Page 21 Page 22 Page 23 … Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights Read more about Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights
Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call Read more about Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call
Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference Read more about Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference
Ardelyx Announces Pricing of Public Offering of Common Stock Read more about Ardelyx Announces Pricing of Public Offering of Common Stock
Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank Read more about Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank
Ardelyx Announces Proposed Public Offering of Common Stock Read more about Ardelyx Announces Proposed Public Offering of Common Stock
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights Read more about Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada Read more about Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada
Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors Read more about Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors